胶质瘤化疗中国专家共识
Chinese experts consensus on chemotherapy for glioma
中国抗癌协会神经肿瘤专业委员会 1陈忠平1
作者信息
- 1. 中山大学肿瘤防治中心,广州 510060
- 折叠
摘要
胶质瘤是最常见的颅内原发性恶性肿瘤.目前,治疗以手术切除为主,辅以放疗和化疗.临床实践证明,胶质瘤化疗极具意义,已被广泛应用于新诊断的胶质瘤术后辅助治疗和复发胶质瘤的挽救治疗.为进一步规范胶质瘤的化疗过程,提高治疗效果,中国抗癌协会神经肿瘤专业委员会组织相关专家,编写了《胶质瘤化疗中国专家共识》(以下简称《共识》),为广大同仁提供临床实际操作参考.《共识》从胶质瘤化疗相关的病理知识、化疗过程中患者管理、影像学评价、不同级别胶质瘤、新诊断或复发患者、如何结合其他治疗策略等角度对化疗方案进行了介绍.
Abstract
Glioma is the most prevalent primary intracranial malignant tumor.At present,the main therapy is surgical resection,supplemented by radiotherapy and chemotherapy.Clinical practice has demonstrated that chemotherapy is highly significant and widely employed in postoperative adjuvant therapy for newly diagnosed gliomas as well as salvage therapy for recurrent cases.In order to further standardize the chemotherapy process of glioma and improve the therapeutic effect,Chinese experts consensus on chemotherapy for glioma was compiled by relevant experts organized by Chinese Society of Neuro-oncology,which aims to provide clinical reference for colleagues during neuro-oncology practice.The consensus introduces the chemotherapy regimen from the perspectives of pathological knowledge related to glioma chemotherapy,patient management during chemotherapy,imaging evaluation,different grades of glioma,newly diagnosed or relapsed patients and how to combine other treatment strategies.
关键词
胶质瘤/高级别胶质瘤/化疗策略/化疗方案/专家共识Key words
Glioma/High grade glioma/Chemotherapy strategies/Chemotherapy regimens/Consensus of Chi-nese experts引用本文复制引用
出版年
2024
NETL
NSTL
万方数据